-
Available Subscriptions
Trotting Chat
3,025 topics in this forum
-
- 9 replies
- 1.3k views
-
- 13 replies
- 1.6k views
-
- 2 replies
- 911 views
-
- 23 replies
- 2k views
-
- 5 replies
- 908 views
-
- 54 replies
- 7.2k views
-
- 11 replies
- 1.4k views
-
- 8 replies
- 1.4k views
-
- 3 replies
- 928 views
-
- 7 replies
- 1.1k views
-
- 3 replies
- 736 views
-
- 16 replies
- 1.7k views
-
- 14 replies
- 1.6k views
-
- 0 replies
- 521 views
-
- 8 replies
- 1.5k views
-
- 0 replies
- 600 views
-
- 22 replies
- 1.7k views
-
- 15 replies
- 1.7k views
-
- 25 replies
- 2.6k views
-
- 7 replies
- 1.2k views
-
- 7 replies
- 1.5k views
-
- 2 replies
- 561 views
-
- 28 replies
- 3.1k views
-
- 0 replies
- 514 views
-
- 51 replies
- 3.8k views
Announcements
-
Posts
-
the life of some racehorses can be fleeting. think about it,was retired after he collapsed and fell to the track 18 months ago, when suffering a massive lung bleed during a race.At the time to most observers it appeared he had collapsed and died,but then he surprised everyone who saw the race and got up and walked away,seemingly looking forward to retirement. Unfortunately last month he got sick again and had to have colic surgery. first signs after the surgery were he had cheated death for a 2nd time,but things took a turn for the worse and he was put down. he was only 7. He had won the everest in 2023 and earned $12m when trained by joe pride. he was a well named horse.people. -
By Wandering Eyes · Posted
Trainer Phil Serpe, who is fighting both in federal court and at the Federal Trade Commission (FTC) level to overturn a two-year suspension imposed by the Horseracing Integrity and Welfare Unit (HIWU) for a clenbuterol positive in one of his trainees, on Wednesday was notified by the FTC that his legal team would not be allowed to have new evidence considered in his nearly 18-month-old case. Serpe's suspension stems from clenbuterol detected in the urine of Fast Kimmie (Oscar Performance) after her Aug. 10, 2024 victory in a $30,000 claiming race at Saratoga Race Course. Clenbuterol is classified as a “banned” substance, meaning it is never to be present in any HISA-regulated Thoroughbred. On Jan. 22, 2026, Serpe's legal team had filed a motion with the FTC to consider additional evidence and for a stay of sanction pending review based on: 1) Affidavits from two of Serpe's employees that “an independent contractor hired to help care for Serpe's horses often carried an inhaler in and around Serpe's barn,” purportedly explaining “a likely alternate source of the clenbuterol in Fast Kimmie's urine.” 2) “[E]vidence that Dr. Daniel Eichner, HIWU's expert witness, has pecuniary relationships with HIWU that compromise his independence” by heading “a private corporation that receives significant revenue by providing testing services for HIWU.” On Feb. 4, April Tabor, the secretary of the FTC, wrote an order that denied, in part, Serpe's request, explaining the denial based on the following reasoning: “As an initial matter, we decline to consider this additional evidence. On a party's motion, we may consider new evidence when it is material to our review and there are reasonable grounds on which the party failed to previously submit it,” Tabor wrote. “Mr. Serpe–who has been ably represented by counsel throughout these proceedings–has not demonstrated reasonable grounds for waiting seventeen months to procure affidavits from two former employees,” Tabor wrote. “He merely notes that he is 'no trained investigator.' “Nor has Mr. Serpe provided reasonable grounds for not earlier presenting the evidence of HIWU's expert's alleged bias,” Tabor wrote. “We are not persuaded that further review of the ALJ's decision as to his liability or suspension is warranted,” Tabor concluded at a different point in the order. Tabor added that, “Mr. Serpe's combined motion remains under consideration to the extent it concerns a stay of his suspension pending a final decision in this case.” A request for comment emailed to Serpe's legal team did not yield a reply prior to deadline for this story. Serpe's separate (but related) lawsuit in United States District Court (Southern District of Florida) is ongoing. Back on Oct. 30, 2025, the federal judge in that case, David Leibowitz, signaled that the 66-year-old trainer could end up prevailing in his overall suit against the FTC and the Horseracing Integrity and Safety Authority (HISA). He wrote that while Serpe “may ultimately win the race, two obstacles stop him from getting a preliminary injunction.” Serpe's injunction was denied by the court at that time because, as the judge wrote, “Serpe does not face a threat of imminent irreparable harm [and] has not demonstrated a substantial likelihood of success on the merits.” Also in that Oct. 30 court order, Judge Leibowitz wrote that, “what happened to [Serpe] in the wake of Fast Kimmie's win goes to the constitutional core of the American judicial system.” But, Leibowitz explained, “The problem for Serpe at this stage of the litigation is that his suspension is disconnected from the basis of his Seventh Amendment challenge, a disconnect that Serpe himself has acknowledged,” the judge wrote. A status report posted to the court's docket for the case stated the parties have agreed that Serpe will file a motion for summary judgment by Feb. 6 and that defendants will file a combined cross-motion for summary judgment and opposition to Plaintiff's motion for summary judgment by Mar. 23. Other deadlines for filings have been set as far out as late May, with no trial date yet posted. Beyond the lawsuit, Serpe's case has been separately handled at the administrative level by HISA, HIWU and the FTC. Serpe has already appealed his penalization before a HIWU arbitrator and the administrative law judge (ALJ) assigned by the FTC, and as part of an FTC order dated Sept. 15, 2025, the FTC will be undertaking a “further review” of the case, which is what is happening now. The post FTC Rules Serpe Cannot Now Introduce New Evidence in 18-Month Old Clenbuterol Case appeared first on TDN | Thoroughbred Daily News | Horse Racing News, Results and Video | Thoroughbred Breeding and Auctions. View the full article -
Well one would think so in certain areas...but the angle I'm coming from is ENTAIN has to protect brand reputation and any criticism of an industry per se directly affects their bottom line I've publicly criticised the industry INTEGRITY arm on many occasions and if ENTAIN finds out wtf it is then this 'persona' is in for the chopping block imho call me a deranged, hypochondriacal paranoid despot if you want...no skin off this nose -
its hard to find horses paying reasonable prices these days. the bookies have the best chances too short,then the tote just follows the prices of the favorites in. Then if you get matt cross tipping the same horse,they end up paying even less. been following my wingman,only paying $1.85 to win today. should win,but $1.85. the best value always seems to come at methven. my tips for methven are race 2. Mithali for aplace at $4.80,race 4 hes a loch at $41 w $8 p,race 5 just easy$26 w and $6 p and race 11 jrtoilen at $2.90 p. so i will tip a multi of my wingman/win,mithali/p,hes a loch p,just easy w and jr tolilken p. For a $1 investment i expect to get $5356. Maybe i will do just easy for a place multi as well and collect $1236.or throw in hes a loch to win in that first multi to win and get $27,451 for my $1. don't say i didn't tell you beforehand.
-
If he HAD crossed the line, he would have been close to being found guilty wouldn't he. Same thing.
-
-
Topics
-
